Skip to content
OpenCapital
Get started

AptarGroup ATR Equity Method Investments

Equity Method Investments at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$209.2M-1.3%
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$15M+36.4%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
——

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S2×-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's equity method investments?
AptarGroup (ATR) reported equity method investments of $130.76M in Q1 2026.
How has AptarGroup's equity method investments changed year-over-year?
AptarGroup's equity method investments decreased by 11.5% year-over-year, from $147.69M to $130.76M.
What is the long-term trend for AptarGroup's equity method investments?
Over 5 years (2020 to 2025), AptarGroup's equity method investments has grown at a 21.2% compound annual growth rate (CAGR), from $50.09M to $131.03M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.